Works about HYDROXYUREA
Results: 784
Chemotherapy-induced leg ulcers: a case series.
- Published in:
- Journal of Wound Care, 2025, v. 34, n. 3, p. 250, doi. 10.12968/jowc.2020.0128
- By:
- Publication type:
- Article
Nails blue? Don't be sad, the cause may be discoverable.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 10, p. 344, doi. 10.1007/s40267-023-01022-z
- By:
- Publication type:
- Article
Antioxidant and Amine Oxidase Inhibitory Activities of Hydroxyurea.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2010, v. 74, n. 6, p. 1256, doi. 10.1271/bbb.100096
- By:
- Publication type:
- Article
Phase II open-label study of single-agent hydroxyurea for treatment of mast cell tumours in dogs.
- Published in:
- Veterinary & Comparative Oncology, 2010, v. 8, n. 2, p. 103, doi. 10.1111/j.1476-5829.2010.00211.x
- By:
- Publication type:
- Article
Sex as an Independent Risk Factor for Venous Thromboembolism in Sickle Cell Disease: A Cross-Sectional Study.
- Published in:
- Journal of Women's Health (15409996), 2022, v. 31, n. 10, p. 1467, doi. 10.1089/jwh.2022.0046
- By:
- Publication type:
- Article
Premature chromosome condensation induced by caffeine, 2-aminopurine, staurosporine and sodium metavanadate in S-phase arrested HeLa cells is associated with a decrease in Chk1 phosphorylation, formation of phospho-H2AX and minor cytoskeletal rearrangements
- Published in:
- Histochemistry & Cell Biology, 2011, v. 135, n. 3, p. 263, doi. 10.1007/s00418-011-0793-3
- By:
- Publication type:
- Article
Synthesis and Cytostatic Activity of (E)-Ethyl-2-Amino-5-(3,3-Dimethyl-4-Oxobutyliden)-4-Oxo-1- (2-Phenylaminobenzamido)-4,5-Dihydro-1Hpyrrol-3-Carboxylate.
- Published in:
- Pharmaceutical Chemistry Journal, 2020, v. 53, n. 10, p. 895, doi. 10.1007/s11094-020-02096-z
- By:
- Publication type:
- Article
Primary Prevention of Stroke in Children With Sickle Cell Anemia in Nigeria: Protocol for a Mixed Methods Implementation Study in a Community Hospital.
- Published in:
- JMIR Research Protocols, 2022, v. 11, n. 6, p. 1, doi. 10.2196/37927
- By:
- Publication type:
- Article
CLINICAL OUTCOMES OF HYDROXYUREA THERAPY IN THE MANAGEMENT OF SICKLE CELL DISEASE IN A TERTIARY HEALTH FACILITY IN SOUTHERN NIGERIA.
- Published in:
- Journal of Pharmaceutical & Allied Sciences, 2024, v. 21, n. 1, p. 4071
- By:
- Publication type:
- Article
Psoriatic patient treatment pathway: systemic treatments.
- Published in:
- Journal of Community Nursing, 2019, v. 33, n. 1, p. 52
- By:
- Publication type:
- Article
A non-electrolyte haemolysis assay for diagnosis and prognosis of sickle cell disease.
- Published in:
- Journal of Physiology, 2013, v. 591, n. 6, p. 1463, doi. 10.1113/jphysiol.2012.246579
- By:
- Publication type:
- Article
Adsorption properties of metal functionalized fullerene (C<sub>59</sub>Au, C<sub>59</sub>Hf, C<sub>59</sub>Ag, and C<sub>59</sub>Ir) nanoclusters for application as a biosensor for hydroxyurea (HXU): insight from theoretical computation.
- Published in:
- Zeitschrift für Physikalische Chemie, 2022, v. 236, n. 11/12, p. 1515, doi. 10.1515/zpch-2022-0126
- By:
- Publication type:
- Article
Evaluation Of SRJ23 And Hydroxyurea In Reducing The Viability Of Cell Line Isolated From Histiocytic Lymphoma.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Nitric Oxide Mediation in Hydroxyurea and Nitric Oxide Metabolites' Inhibition of Erythroid Progenitor Growth.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 11, p. 1562, doi. 10.3390/biom11111562
- By:
- Publication type:
- Article
Common Chemical Inductors of Replication Stress: Focus on Cell-Based Studies.
- Published in:
- Biomolecules (2218-273X), 2017, v. 7, n. 1, p. 19, doi. 10.3390/biom7010019
- By:
- Publication type:
- Article
LYSOZYME NEPHROPATHY IN HAEMATOLOGICALLY STABLE CHRONIC MYELOMONOCYTIC LEUKAEMIA.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Cost-Effectiveness of Hydroxyurea for Sickle Cell Anemia in a Low-Income African Setting: A Model-Based Evaluation of Two Dosing Regimens.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 12, p. 1603, doi. 10.1007/s40273-023-01294-3
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacodynamics of hydroxyurea.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Hydroxyurea Therapy Mobilises Arachidonic Acid from Inner CellMembrane Aminophospholipids in Patients with Homozygous Sickle Cell Disease.
- Published in:
- Journal of Lipids, 2011, p. 1, doi. 10.1155/2011/718014
- By:
- Publication type:
- Article
Treatment Patterns and Blood Counts in Patients With Polycythemia Vera Treated With Hydroxyurea in the United States: An Analysis From the REVEAL Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Outcome of Imatinib Treatment in Yemeni Patients With Chronic Myeloid Leukemia and the Influence of Nonadherence to Treatment and Duration of Previous Hydroxyurea Therapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Interferon Alpha Has a Strong Anti-tumor Effect in Philadelphia-negative Myeloproliferative Neoplasms.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Evolving Therapeutic Options for Polycythemia Vera: Perspectives of the Canadian Myeloproliferative Neoplasms Group.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Proportion of Adults With Sickle Cell Anemia and Pain Crises Receiving Hydroxyurea.
- Published in:
- JAMA: Journal of the American Medical Association, 2015, v. 313, n. 16, p. 1671, doi. 10.1001/jama.2015.3075
- By:
- Publication type:
- Article
Management of Sickle Cell Disease Summary of the 2014 Evidence-Based Report by Expert Panel Members.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 312, n. 10, p. 1033, doi. 10.1001/jama.2014.10517
- By:
- Publication type:
- Article
Alpha Globin Gene Mutation: A Major Determinant of Hydroxyurea Response in Transfusion-Dependent HbE-β-Thalassaemia.
- Published in:
- Acta Haematologica, 2019, v. 142, n. 3, p. 132, doi. 10.1159/000495453
- By:
- Publication type:
- Article
Combination Therapy with Ruxolitinib and Hydroxyurea for the Treatment of Myeloid-Predominant Leukocytosis in a Patient with Myelofibrosis.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Hydroxyurea Increases Plasma Concentrations of Microparticles and Reduces Coagulation Activation and Fibrinolysis in Patients with Sickle Cell Anemia.
- Published in:
- Acta Haematologica, 2015, v. 133, n. 3, p. 287, doi. 10.1159/000362148
- By:
- Publication type:
- Article
Clinical Follow-Up of Hydroxyurea-Treated Adults with Sickle Cell Disease.
- Published in:
- Acta Haematologica, 2011, v. 125, n. 3, p. 145, doi. 10.1159/000322248
- By:
- Publication type:
- Article
Wild-Type JAK2 Secondary Acute Erythroleukemia Developing after JAK2-V617F-Mutated Primary Myelofibrosis.
- Published in:
- Acta Haematologica, 2009, v. 122, n. 1, p. 36, doi. 10.1159/000235773
- By:
- Publication type:
- Article
Hydroxyurea therapy for children with sickle cell disease: describing how caregivers make this decision.
- Published in:
- BMC Research Notes, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s13104-015-1344-0
- By:
- Publication type:
- Article
Treatment of Acute Promyelocytic Leukemia in a 94-Year-Old Male Patient: A Case Report.
- Published in:
- International Journal of Gerontology, 2022, v. 16, n. 2, p. 150, doi. 10.6890/IJGE.202204_16(2).0015
- By:
- Publication type:
- Article
Update in the myeloproliferative neoplasms.
- Published in:
- Clinical Medicine, 2014, v. 14, p. s66, doi. 10.7861/clinmedicine.14-6-s66
- By:
- Publication type:
- Article
Use of the oxygen gradient ektacytometry in the dose titration of hydroxyurea therapy in children with sickle cell disease.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Impact of splenectomy on circulating microparticles in patients with sickle cell anemia.
- Published in:
- International Journal of Laboratory Hematology, 2024, v. 46, n. 1, p. 141, doi. 10.1111/ijlh.14162
- By:
- Publication type:
- Article
Chronic neutrophilic leukemia associated with thrombocytosis and a CSF3R Q781* nonsense mutation.
- Published in:
- International Journal of Laboratory Hematology, 2023, v. 45, n. 3, p. e79, doi. 10.1111/ijlh.14015
- By:
- Publication type:
- Article
A case of extramedullary T‐lymphoblastic blast crisis as an initial presentation of chronic myelogenous leukemia.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Chip‐based digital polymerase chain reaction technology is useful for monitoring the JAK2 V617F allele burden in Philadelphia‐negative myeloproliferative neoplasms.
- Published in:
- International Journal of Laboratory Hematology, 2019, v. 41, n. 5, p. e113, doi. 10.1111/ijlh.13013
- By:
- Publication type:
- Article
Sickle cell disease: Reducing the global disease burden.
- Published in:
- International Journal of Laboratory Hematology, 2019, v. 41, p. 82, doi. 10.1111/ijlh.13023
- By:
- Publication type:
- Article
Influence of β<sup>S</sup> allele in the lipid peroxidation and antioxidant capacity parameters.
- Published in:
- International Journal of Laboratory Hematology, 2014, v. 36, n. 2, p. 205, doi. 10.1111/ijlh.12154
- By:
- Publication type:
- Article
Response to case report: Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy.
- Published in:
- 2017
- By:
- Publication type:
- Letter to the Editor
Sickle cells are not necessarily protective against falciparum- A case report.
- Published in:
- Asian Journal of Transfusion Science, 2022, v. 16, n. 2, p. 266, doi. 10.4103/ajts.ajts_122_21
- By:
- Publication type:
- Article
Effect of leukapheresis on pain reduction in leukemic priapism.
- Published in:
- Asian Journal of Transfusion Science, 2022, v. 16, n. 1, p. 124, doi. 10.4103/ajts.ajts_160_21
- By:
- Publication type:
- Article
Retinal changes in children and adolescents with sickle cell disease attending a paediatric hospital in Cairo, Egypt: risk factors and relation to ophthalmic and cerebral blood flow.
- Published in:
- Transactions of the Royal Society of Tropical Medicine & Hygiene, 2013, v. 107, n. 4, p. 205, doi. 10.1093/trstmh/trt008
- By:
- Publication type:
- Article
Chronic myelomonocytic leukaemia: leukaemia cutis predicts disease progression.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
High rate of long-term survivals in AML treated by chemotherapy and androgenotherapy: a pilot study.
- Published in:
- 1980
- By:
- Publication type:
- journal article
Cell kinetic studies in patients with small cell carcinoma of the lung.
- Published in:
- 1974
- By:
- Publication type:
- journal article
Dry gangrene in a patient with sickle cell disease on hydroxyurea: a case report.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Anhidrosis associated with long-term use of hydroxyurea in a patient with myeloproliferative neoplasm.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 7, p. 1595, doi. 10.1007/s00277-022-04790-2
- By:
- Publication type:
- Article
Hydroxyurea and fetal hemoglobin effect on leg ulcers in patients with sickle cell disease.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 3, p. 541, doi. 10.1007/s00277-021-04635-4
- By:
- Publication type:
- Article